[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons].
Cazzola
M
M
Dipartimento di Medicina Interna e Terapia Medica, Università, Pavia.
Pedrazzoli
P
P
Bergamaschi
G
G
Buonanno
C
C
Cuomo
A
A
D'Uva
R
R
Ponchio
L
L
Rosti
V
V
Zappone
E
E
Ascari
E
E
D002455:Cell Division / Q000187:drug effects; D002869:Chromosome Aberrations; D002999:Clone Cells / Q000473:pathology; D005819:Genetic Markers; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000473:pathology; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000494:pharmacology / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000209:etiology* / Q000235:genetics / Q000473:pathology / Q000628:therapy; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000473:pathology; D009857:Oncogenes; D011994:Recombinant Proteins
D005819:Genetic Markers; D007370:Interferon Type I; D011994:Recombinant Proteins; D007371:Interferon-gamma
Meccanismi patogenetici della leucemia mieloide cronica ed effetti antiproliferativi degli interferoni alfa e gamma.